Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0034186 (
pyelonephritis
)
6,144
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Our immune system has to constantly strike a balance between activation and inhibition of an inflammatory response to combat invading pathogens and avoid inflammation-induced collateral tissue damage. Toll interleukin-1 receptor 8 (IL-1R-8)/single Ig domain IL-1R-related molecule (
TIR8
/
SIGIRR
) is an inhibitor of Toll-like receptor (TLR)/IL-1R signaling, which is predominantly expressed in the kidney. The biological role of renal
TIR8
during infection is, however, unknown. We therefore evaluated renal
TIR8
expression during Escherichia coli
pyelonephritis
and explored its role in host defense using
TIR8
(-/-) versus
TIR8
(+/+) mice. We found that
TIR8
protein is abundantly present in the majority of cortical tubular epithelial cells.
Pyelonephritis
resulted in a significant downregulation of
TIR8
mRNA in kidneys of
TIR8
(+/+) mice.
TIR8
inhibited an effective host response against E. coli, as indicated by diminished renal bacterial outgrowth and dysfunction in
TIR8
(-/-) mice. This correlated with increased amounts of circulating and intrarenal neutrophils at the early phase of infection.
TIR8
(-/-) tubular epithelial cells had increased cytokine/chemokine production when stimulated with lipopolysaccharide (LPS) or heat-killed E. coli, suggesting that
TIR8
played an anti-inflammatory role during pathogen stimulation by inhibiting LPS signaling. These data suggest that
TIR8
is an important negative regulator of an LPS-mediated inflammatory response in tubular epithelial cells and dampens an effective antibacterial host response during
pyelonephritis
caused by uropathogenic E. coli.
...
PMID:The toll interleukin-1 receptor (IL-1R) 8/single Ig domain IL-1R-related molecule modulates the renal response to bacterial infection. 2289 Sep 91